ELK1 and bladder transitional cell carcinoma: The authors reported that incubation with 12-O-tetra-decanoylphorbol 13-acetate (TPA) which is a Protein kinase C (PKC) agonist, leads to profound ELK1 activation in urinary bladder transitional cell carcinoma (TCC) cell lines [250] (Figure 3).